{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:34:38Z","timestamp":1791056078602,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"DOI":"10.1097\/qai.0b013e318166af5d","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T03:02:56Z","timestamp":1207882976000},"page":"13-19","source":"Crossref","is-referenced-by-count":41,"title":["Long-Term Monitoring of Visceral Leishmaniasis in Patients With AIDS"],"prefix":"10.1097","volume":"48","author":[{"given":"Nathalie","family":"Bourgeois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aba","family":"Mahamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe.","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus co-infection: the first 10 years.","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.","volume":"80","author":"Pintado","year":"2001","journal-title":"Medicine"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/JCM.32.3.746-749.1994","article-title":"Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients.","volume":"32","author":"Piarroux","year":"1994","journal-title":"J Clin Microbiol"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1128\/JCM.33.5.1145-1149.1995","article-title":"PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs.","volume":"33","author":"Mathis","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/JCM.38.1.236-240.2000","article-title":"Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients.","volume":"38","author":"Lachaud","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.39.1.357-361.2001","article-title":"Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.","volume":"39","author":"Pizzuto","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","article-title":"Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8 year experience in Italy and review of the literature.","volume":"44","author":"Antinori","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity.","volume":"42","author":"Mary","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.","volume":"41","author":"Bossolasco","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1016\/S0035-9203(02)90075-1","article-title":"A nested polymerase chain reaction for diagnosis and follow-up of human visceral leishmaniasis patients using blood samples.","volume":"96","author":"Fisa","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 1","key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus.","volume":"96","author":"Cruz","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4269\/ajtmh.2005.73.1012","article-title":"Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with Leishmania and human immunodeficiency virus.","volume":"73","author":"Riera","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkm294","article-title":"Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.","volume":"60","author":"Molina","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1097\/00002030-200012220-00020","article-title":"Discontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.","volume":"14","author":"Berenguer","year":"2000","journal-title":"AIDS"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","article-title":"Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy.","volume":"19","author":"Villanueva","year":"2000","journal-title":"Eur J Clin Microbiol"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s100960100457","article-title":"Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.","volume":"20","author":"Casado","year":"2001","journal-title":"Eur J Clin Microbiol"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-patients.","volume":"53","author":"Lopez-Velez","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"RR-17","key":"R20-2-20210131","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimonate with amphotericin B. Spanish HIV-Leishmania Study Group.","volume":"13","author":"Laguna","year":"1999","journal-title":"AIDS"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4269\/ajtmh.2004.70.298","article-title":"Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.","volume":"70","author":"Mira","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1198-743x.2001.00270.x","article-title":"Decline of visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly antiretroviral therapy.","volume":"7","author":"Lopez-Velez","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/344325","article-title":"Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.","volume":"186","author":"Del Giudice","year":"2002","journal-title":"J Infect Dis"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/IAI.69.2.1212-1214.2001","article-title":"T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB\/c mice.","volume":"69","author":"Schilling","year":"2001","journal-title":"Infect Immun"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0031182002002081","article-title":"Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers.","volume":"125","author":"Lachaud","year":"2002","journal-title":"Parasitology"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","article-title":"HIV viral load and response to antileishmanial chemotherapy in co-infected patients.","volume":"13","author":"Berhe","year":"1999","journal-title":"AIDS"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/JCM.40.3.762-767.2002","article-title":"Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type-1 infected patients from Spain in the era of highly active antiretroviral therapy.","volume":"40","author":"De la Rosa","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/000349803225002615","article-title":"The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.","volume":"97","author":"Lopez-Velez","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"R31-2-20210131","first-page":"152","article-title":"Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.","volume":"13","author":"Jimenez-Exposito","year":"1999","journal-title":"AIDS"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/IAI.67.10.5258-5264.1999","article-title":"Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication.","volume":"67","author":"Wolday","year":"1999","journal-title":"Infect Immun"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2004.06.003","article-title":"Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network.","volume":"113","author":"Zhao","year":"2004","journal-title":"Clin Immunol"},{"key":"R34-2-20210131","first-page":"160","article-title":"Prevention of opportunistic infections in HIV-infected adolescents and adults. Recommendations of GESIDA\/National AIDS Plan.","volume":"22","author":"Berenguer","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1128\/IAI.69.12.7365-7373.2001","article-title":"Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.","volume":"69","author":"Garin","year":"2001","journal-title":"Infect Immun"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.321.7264.801","article-title":"Medicine and the future: leishmaniasis.","volume":"321","author":"Roberts","year":"2000","journal-title":"BMJ"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1086\/432885","article-title":"Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.","volume":"41","author":"Stebbing","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"14","author":"Soriano","year":"2000","journal-title":"AIDS"},{"key":"R39-2-20210131","first-page":"50","article-title":"Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.","volume":"37","author":"Liao","year":"2004","journal-title":"J Microbiol Immunol Infect"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318166af5d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:57:31Z","timestamp":1786035451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200805010-00002"}},"subtitle":["Relapse Risk Factors, Value of Polymerase Chain Reaction, and Potential Impact on Secondary Prophylaxis"],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318166af5d","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}